Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes. (Q43013022)
Jump to navigation
Jump to search
scientific article published in August 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes. |
scientific article published in August 2010 |
Statements
Pitavastatin and 4'-hydroxy-3'-methoxyacetophenone (HMAP) reduce cognitive dysfunction in vascular dementia during experimental diabetes (English)
1 August 2010